For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of Leeds

Return to search Previous output Next output
Output 22 of 347 in the submission
Article title

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Type
D - Journal article
Title of journal
Lancet
Article number
-
Volume number
377
Issue number
9783
First page of article
2103
ISSN of journal
0140-6736
Year of publication
2011
URL
-
Number of additional authors
21
Additional information

I made a substantial contribution to the conception and design of the study.

I made a substantial contribution to the organisation and conduct of the study.

I made a substantial contribution to carrying out the study, including acquisition of study data.

I made a substantial contribution to analysis and interpretation of study data.

I helped critique the output for important intellectual content.

Interdisciplinary
-
Cross-referral requested
-
Research group
A - Cancer
Citation count
171
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-